| scholarly article | Q13442814 |
| P2093 | author name string | Christian Mueller | |
| Terence R Flotte | |||
| Qiushi Tang | |||
| Allison Keeler | |||
| Sofia Braag | |||
| Timothy Menz | |||
| P2860 | cites work | IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1 | Q24290462 |
| IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo | Q28213431 | ||
| A family of small inducible proteins secreted by leukocytes are members of a new superfamily that includes leukocyte and fibroblast-derived inflammatory agents, growth factors, and indicators of various activation processes | Q28247742 | ||
| Interleukin-13: central mediator of allergic asthma | Q28291712 | ||
| Genetic Susceptibility to Asthma — Bronchial Hyperresponsiveness Coinherited with a Major Gene for Atopy | Q28296979 | ||
| The pros and cons of immunomodulatory IL-10 gene therapy with recombinant AAV in a Cftr-/- -dependent allergy mouse model | Q33381294 | ||
| Activated mast cells produce interleukin 13. | Q36364660 | ||
| Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune response | Q36370595 | ||
| IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand | Q36696547 | ||
| A functional IL-13 receptor is expressed on polarized murine CD4+ Th17 cells and IL-13 signaling attenuates Th17 cytokine production | Q37012219 | ||
| Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy | Q37364038 | ||
| Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production | Q40849898 | ||
| IL-13 production by NK cells: IL-13-producing NK and T cells are present in vivo in the absence of IFN-gamma. | Q40981505 | ||
| Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans | Q42476540 | ||
| Pulmonary T(H)2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis | Q44434322 | ||
| Partial correction of the CFTR-dependent ABPA mouse model with recombinant adeno-associated virus gene transfer of truncated CFTR gene | Q45399177 | ||
| Enhanced IgE allergic response to Aspergillus fumigatus in CFTR-/- mice. | Q54621653 | ||
| Purified human peripheral blood basophils release interleukin-13 and preformed interleukin-4 following immunological activation | Q61960815 | ||
| Correction of lethal intestinal defect in a mouse model of cystic fibrosis by human CFTR | Q71661844 | ||
| Interleukin-2 secretion by human B lymphocytes occurs as a late event and requires additional stimulation after CD40 cross-linking | Q71696205 | ||
| Interleukin-13 and interleukin-4 are coexpressed in atopic asthma | Q71747952 | ||
| IL-4 induces human B cell maturation and IgE synthesis in SCID-hu mice. Inhibition of ongoing IgE production by in vivo treatment with an IL-4/IL-13 receptor antagonist | Q71829402 | ||
| IL-10 and IL-13 as B cell growth and differentiation factors | Q72088630 | ||
| The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation | Q74195817 | ||
| Increased expression of Interleukin-13 but not Interleukin-4 in cystic fibrosis patients | Q80819694 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 511-518 | |
| P577 | publication date | 2009-11-24 | |
| P1433 | published in | Molecular Therapy | Q15762400 |
| P1476 | title | Modulation of exaggerated-IgE allergic responses by gene transfer-mediated antagonism of IL-13 and IL-17e | |
| P478 | volume | 18 |
| Q36251378 | Central Role of IL-23 and IL-17 Producing Eosinophils as Immunomodulatory Effector Cells in Acute Pulmonary Aspergillosis and Allergic Asthma. |
| Q42176534 | Dynamic role of epithelium-derived cytokines in asthma |
| Q35750626 | Liposome-based polymer complex as a novel adjuvant: enhancement of specific antibody production and isotype switch |
Search more.